Like Patient Profiles, LLC

closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/3/2014 via PR Newswire

TrialScope, acquired PharmaCM

synopsis: TrialScope, a provider of clinical trial solutions and services, announced its acquisition of substantially all of the assets of Deloitte Analytics LLC, including the PharmaCM business which provides technology solutions for clinical trial registration and transparency.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target parent: Deloitte LLP
target: PharmaCM
PharmaCM is a content management platform designed specifically for the regulated environment of Life Sciences. The PharmaCM platform is the basis for a number of modules developed to address specific content management and workflow challenges across the clinical and regulatory content value chain.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/13/2019 via BusinessWire

Saama Technologies, will acquire Comprehend Systems, Inc.

synopsis: Saama Technologies, Inc., the advanced clinical data and analytics company, announced that it has signed a definitive agreement to acquire Comprehend Systems, Inc., a company that provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process.
buyer: Saama Technologies
Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. "
target: Comprehend Systems, Inc.
Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2014 via Company Press Release

ERT, acquired eClinical Insights, Inc.

synopsis: ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, announced the acquisition of eClinical Insights (eCI), an innovative provider of cloud-based clinical trials management software.
buyer parent: Genstar Capital LLC
buyer: ERT
ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data. "
target: eClinical Insights, Inc.
eClinical Insights® is a leading-edge provider of cloud-based clinical software that provides clinical research professionals with the strategic visibility to make rapid, data-driven decisions to positively impact the performance and cost of their clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2013 via Company Press Release

Litéra Corp, purchased AxxiTRIALS from Axxiem Web Solutions

synopsis: Litera has announced the acquisition of AxxiTRIALS from Axxiem Web Solutions. AxxiTRIALS is a leading Clinical Trials Portal solution providing life science companies and clinical research organizations (CROs) with a platform designed to dramatically speed site start-up, patient recruitment, and end-to-end clinical trial operations.
buyer: Litéra Corp
Litéra Corp. engages in developing and marketing content lifecycle management solutions for law firms and corporations worldwide. It offers document creation, comparison, collaboration, and cleansing software solutions that manage documents throughout their lifecycle. "
seller: Axxiem Web Solutions
AxxiTRIALS developed by Axxiem is a web-based clinical trials communication portal. AxxiTRIALS provides a simple and secure way to efficiently distribute and track time-sensitive documents and training materials to users around the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/24/2009 via PR Newswire

OmniComm Systems, Inc., purchased EDC Solutions from eResearch Technology, Inc.

synopsis: OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, has acquired the EDC business of eResearchTechnology, Inc., a global provider of technology and services that enable life science industries worldwide to collect, interpret, and distribute cardiac safety and clinical data.
buyer: OmniComm Systems, Inc. (OTCPK:OMCM:$24.62)
OmniComm Systems, Inc. provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. "
seller: eResearch Technology, Inc.
eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently.
price ($mm)[EV]
$2.02 [$0.87]
rev ($mm)
$6
EBITDA ($mm)
EV / rev
0.1x
EV / EBITDA
closed 7/15/2009 via BusinessWire

Merge Healthcare, acquired etrials, Inc.

synopsis: Merge Healthcare Inc., a leading health IT solutions provider, and etrials Worldwide, Inc., a leading provider of clinical trials software and services, announced the expiration of the exchange offer for the shares of etrials’ common stock by Merge Acquisition Corp. Merge now owns approximately 86% of the outstanding shares of Etrials common stock.
buyer: Merge Healthcare (MRGE:$227.59)
Merge Healthcare Incorporated builds software solutions that automate healthcare data and diagnostic workflow to build a better electronic record of the patient experience. "
target: etrials, Inc.
etrials has earned the loyalty of its healthcare partners by guiding them to simplify and accelerate the processes associated with collecting data in clinical trials. Using innovative technologies and proven business processes, etrials offers the most efficient data management products and services.
price ($mm)[EV]
$21 [$14]
rev ($mm)
$16
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 3/25/2008 via BusinessWire

Bio-Imaging Technologies, Inc., acquired Phoenix Data Systems Inc.

synopsis: Bio-Imaging Technologies, Inc. it has acquired privately held Phoenix Data Systems, Inc., a leading global clinical data services provider of electronic data capture services and a comprehensive array of broadly interoperable eClinical data solutions to the pharmaceutical and biotechnology industries.
buyer: Bio-Imaging Technologies, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target: Phoenix Data Systems Inc.
Phoenix Data Systems delivers Full Service EDC, a unique combination of electronic data capture, interactive voice response, reporting, and data management services that give clinical data managers improved control to run well-managed studies.
price ($mm)[EV]
$19 [$18]
rev ($mm)
$12
EBITDA ($mm)
$1
EV / rev
1.8x
EV / EBITDA
15.4x
announced 6/15/2016 via PR Newswire

The WIRB-Copernicus Group, will purchase Clinical Trial Applications from karmadata

synopsis: WIRB-Copernicus Group, one of the world's leading providers of solutions that measurably improve the quality of clinical research, will acquire from karmadata a suite of proprietary applications designed to facilitate the management of clinical trial data. karmadata is the market leader in clinical trial database and decision support applications.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is one of the world's leading providers of solutions that measurably improve the quality and efficience of clinical research. WCG enables biopharmaceutical companies, Clinical Services Organizations and institutions to accelerate the delivery of new treatments. "
seller: karmadata
Karmadata is able to standardize and link the world's healthcare data ranging from leading open data sources to priva pharmacy and medical claims. Its propriety applications are designed to facilitate the management of clinical trial data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/30/2019 via BusinessWire

Evidera, will acquire Medimix International

synopsis: Evidera, a business unit of PPD, LLC, and a provider of evidence-based solutions demonstrating the real-world effectiveness and safety of health care products, will acquire Medimix International, a global technology company providing real-world evidence (RWE) insights and information to the pharmaceutical, diagnostic and medical device industries.
buyer parent: Carlyle Group
buyer: Evidera
Evidera, a PPD business unit, is a leading provider of evidence-based solutions to demonstrate the real-world effectiveness, safety and value of health care products. They help biopharmaceutical, biotechnology and medical device companies generate the evidence needed to optimize the market access. "
target: Medimix International
Medimix International specializes in providing business understanding, real-world evidence insights to the pharmaceutical and medical device industries. Medimix’s primary solution, LiveTracker™, is a cloud-based platform that provides real-time monitoring of clients’ particular therapeutic markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2014 via PR Newswire

Decision Resources Group, acquired Relay Technology Management

synopsis: Piramal Enterprises' Information Management Subsidiary, Decision Resources Group, one of the world's leading research and advisory firms focusing on high-value healthcare insights and analytics, announced that it acquired Relay Technology Management, a data analytics company focused on the life-sciences industry.
buyer parent: Piramal Group
buyer: Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. The top biopharmaceutical, medical technology and managed care companies rely on the Company’s predictive analytics to make fully informed decisions. "
target: Relay Technology Management
Relay Technology Management is a life sciences business intelligence software provider founded in 2008 with one core belief: that enabling data-driven decision-making via objective, standard asset valuation and trend analytics will lead to increased efficiency in drug development.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2011 via BusinessWire

Computer Sciences Corporation, acquired Image Solutions, Inc.

synopsis: Computer Sciences Corporation announced it has closed the acquisition of Image Solutions, Inc. (ISI), a privately-held, global leader in regulatory submission management solutions and related implementation and outsourcing services for the Life Sciences sector.
buyer: Computer Sciences Corporation (DXC:$19,577.00)
Computer Sciences Corporation is a global leader in providing technology-enabled solutions and services through three primary lines of business. These include Business Solutions & Services, the Managed Services Sector and the North American Public Sector. "
target: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2009 via BusinessWire

Apyx, Inc. merged with Image Solutions, Inc.,

synopsis: ISI, a leading provider of software and services for the life sciences industry, announced that it has acquired Apyx, Inc. The merger adds muscle to ISI’s already-growing professional services business, and enhances the company’s broad range of offerings in submissions management and outsourcing.
buyer: Image Solutions, Inc.
Founded in 1992, Image Solutions, Inc. (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. "
target: Apyx, Inc.
Apyx, Inc. provides regulatory strategy and submission management tools and services to help Life Science companies expedite the regulatory submission process, reduce associated expenses and improve document and overall submission quality.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/19/2020 via Company Press Release

Capvis Equity, will acquire BSI Business Systems Integration

synopsis: Capvis AG, a leading private equity firm in Switzerland, will acquire a majority stake in BSI Business Systems Integration AG, a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers.
buyer: Capvis Equity
Capvis is the leading private equity firm in Switzerland and a top player in German-speaking Europe. Capvis invests in well-positioned midsize firms with headquarters in Switzerland, Germany or Austria, typically as part of succession solutions and corporate spin-offs. "
target: BSI Business Systems Integration
Business Systems Integration (BSI) is a Swiss customer relationship management (CRM) software solution provider. BSI offers an omnichannel CRM and marketing automation platform that helps businesses to better support their customers. BIS also offers a clinical trial management software solution.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$24.62)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,061.43)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,061.43)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
announced 6/12/2018 via BusinessWire

Medidata Solutions Worldwide, will acquire SHYFT Analytics

synopsis: Medidata announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. "
target: SHYFT Analytics
SHYFT Analytics is the leading cloud data analytics platform for life sciences with solutions designed exclusively for the pharmaceutical and biotech industry.
price ($mm)
$195
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/17/2017 via BusinessWire

Medidata Solutions Worldwide, will acquire Mytrus, Inc.

synopsis: Medidata, provider of cloud-based solutions and data analytics for clinical research, announced that the company has agreed to acquire Mytrus, an e-clinical technology company specializing in patient-centered electronic informed consent and virtual trials. Medidata will integrate Enroll™, Mytrus’ eConsent solution, into the Medidata Clinical Cloud.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Medidata helps advance the scientific goals of life sciences customers worldwide. "
target: Mytrus, Inc.
Mytrus is an e-clinical technology company specializing in patient-centered electronic informed consent and data collection tools. Mytrus has developed technologies for patients including Enroll for eConsent, Engage for virtual studies and Enroll ID for biosample consent tracking and management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/1/2017 via BusinessWire

Medidata Solutions Worldwide, will acquire CHITA

synopsis: Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research, has agreed to acquire CHITA, a cloud-based content management and collaboration system built on Box Platform, a suite of enterprise-grade content management and collaboration APIs from Box.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. Medidata Clinical Cloud brings quality to the clinical testing of promising medical treatments."
target: CHITA
CHITA is introducing a breakthrough content management and collaboration platform that is fully integrated with Box platform that will allow users to create, store, view, collaborate on and edit both regulated and non-regulated content in a single application.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2016 via BusinessWire

Medidata Solutions Worldwide, acquired Intelemage

synopsis: Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, announced the acquisition of Intelemage, a global pioneer in medical image sharing and workflow management. Intelemage powers medical image file sharing in clinical trials as well as for hospitals, physicians, research institutions and core labs.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. Medidata Clinical Cloud brings quality to the clinical testing of promising medical treatments."
target: Intelemage
Intelemage was founded in 2007 and is currently powering the medical image and clinical data collaboration activities for medical device and pharmaceutical companies, core labs, CROs, hospitals and physicians.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2011 via Company Press Release

Medidata Solutions Worldwide, acquired Clinical Force Inc.

synopsis: Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, has acquired Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of SaaS clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced solutions lower the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Clinical Force Inc.
Clinical Force is a privately-held company with a strong life science pedigree and offices in the US and Europe. It delivers a fully functional Clinical Trials Management System (CTMS) deployed in four continents. Clinical Force has extensive experience in CROs and sponsors.
price ($mm)
$4.40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/17/2008 via BusinessWire

Medidata Solutions Worldwide, acquired Fast Track Systems, Inc.

synopsis: Medidata Solutions, a global provider of electronic data capture, management and reporting solutions, announced the completion of its acquisition of Fast Track Systems, Inc., a provider of clinical trial planning software, proprietary contracting data and professional services.
buyer parent: Insight Venture Partners
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading provider of clinical trial solutions that enable the world’s most advanced life science organizations to maximize the value of their clinical research investments by putting powerful tools into researchers’ hands. "
target: Fast Track Systems, Inc.
Fast Track Systems, Inc. is a provider of data-rich enterprise software and service solutions helping pharmaceutical and biotechnology companies to optimize their clinical development process. We are dramatically improving the efficiency and effectiveness of drug development.
price ($mm)
$18
rev ($mm)
$5
EBITDA ($mm)
EV / rev
3.4x
EV / EBITDA
closed 10/28/2014 via Company Press Release

Medidata Solutions Worldwide, acquired Patient Profiles, LLC

synopsis: Medidata Solutions, the leading global provider of cloud-based solutions for clinical research in life sciences, announced it has acquired Patient Profiles, LLC. They are an early-stage software company focused on clinical data analytics in clinical trials.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Patient Profiles, LLC
Patient Profiles, LLC was founded in 2013 to develop software to improve the efficiency of clinical trials. The Company’s “Patient Profiles” software makes individual reports for every patient in a clinical trial.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/20/2019 via BNC Analysis

Monterro, acquired Viedoc

synopsis: Monterro, the leading B2B software investor in the Nordics, has acquired a majority stake in Viedoc, a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently.
buyer: Monterro
Sweden-based Monterro is the leading B2B software investor in the Nordics, with a mission to turn software companies into market leaders. With operational experience from successfully developing and running companies, Monterro actively supports its portfolio companies in all aspects of growth. "
target: Viedoc
Viedoc is a modern and sophisticated electronic data capture (EDC) system. Viedoc enables researchers to gather and evaluate clinical trial data more efficiently. Their powerful EDC system has been used in over 2000 trials in more than 75 countries in all therapeutic areas and clinical phases.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/24/2019 via BNC Analysis

TrialScope, acquired Clinical Trial Connect, LLC

synopsis: TrialScope has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. As part of the acquisition, founder Mike Wenger will share his technological expertise as part of the TrialScope team.
buyer: TrialScope
TrialScope is the global leader in clinical trial transparency and compliance. TrialScope's tools and systems enable their customers to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater business success. "
target: Clinical Trial Connect, LLC
Clinical Trial Connect is a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trials. Clinical Trial Connect was founded by Mike Wenger, who developed his own algorithm for matching patients to clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2019 via BNC Analysis

JLL Partners, Water Street Healthcare Partners, acquired THREAD Research

synopsis: Water Street Healthcare Partners and JLL Partners have acquired Orange County, California-based THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
buyer: JLL Partners
buyer: Water Street Healthcare Partners
JLL Partners is a middle-market private equity firm with a 30-year track record of building and transforming businesses. Water Street is a strategic investor focused exclusively on healthcare. The firm has a strong record of building market-leading companies across key growth sectors in healthcare. "
target: THREAD Research
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/17/2019 via GlobeNewswire

Anju Software, will acquire OmniComm Systems, Inc.

synopsis: Anju Software, a leading provider of comprehensive software solutions to the life sciences industry, will be acquiring OmniComm, a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services.
buyer parent: ABRY Partners, LLC
buyer: Anju Software
Anju Software, Inc. is a leading provider of comprehensive software solutions to the life sciences industry that provides an integrated platform spanning clinical operations, medical affairs, and commercial divisions, including integrated data intelligence. "
target: OmniComm Systems, Inc. (OTCPK:OMCM:$24.62)
OmniComm is a healthcare technology company that provides web-based electronic data capture and eClinical solutions and related value-added services to pharmaceutical and biotech companies, contract research organizations, and other clinical trial sponsors.
price ($mm)[EV]
$72 [$81]
rev ($mm)
$25
EBITDA ($mm)
$2
EV / rev
3.4x
EV / EBITDA
46.2x
announced 6/12/2019 via BusinessWire

Dassault Systemes, will acquire Medidata

synopsis: Dassault Systèmes, a provider of solutions that transform the way products are designed, provided and supported, will be acquiring Medidata, a provider of a platform for clinical development, commercial, and real-world data.
buyer: Dassault Systemes (ENXTPA:DSY:$5,061.43)
Based in France, Dassault Systèmes provides clients with virtual universes to imagine sustainable innovations. Its solutions transform the way products are designed, produced, and supported. They foster social innovation, expanding possibilities for the virtual world to improve the real world. "
target: Medidata (MDSO:$660.00)
Medidata is leading the digital transformation of life science, with a platform for clinical development, commercial, and real-world data. Powered by artificial intelligence, Medidata helps accelerate value, minimize risk and optimize outcomes.
price ($mm)[EV]
$5,825 [$5,822]
rev ($mm)
$660
EBITDA ($mm)
$81
EV / rev
8.8x
EV / EBITDA
72.2x
closed 4/10/2019 via BNC Analysis

TriNetX, acquired Custodix N.V.

synopsis: TriNetX has acquired Custodix, a Belgian-based provider of clinical trial patient recruitment solutions. TriNetX is a global health research network that has revolutionised clinical research. Custodix is a provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance.
buyer: TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and CROs to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. "
target: Custodix N.V.
Custodix is a Belgian provider of clinical trial patient recruitment solutions offering a range of solutions for ensuring compliance with European and US data protection legislation and security best practices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/17/2018 via Company Press Release

Oracle Corporation, will acquire GoBalto

synopsis: Oracle announced that it has entered into an agreement to acquire goBalto, which delivers leading cloud solutions to accelerate clinical trials by streamlining and automating the selection and set up of the best performing clinical research sites to conduct trials.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is a computer technology corporation developing and marketing computer hardware systems and enterprise software products. By eliminating complexity and simplifying IT, Oracle enables its customers to accelerate innovation and create added value for their customers. "
target: GoBalto
goBalto, Inc. is an award winning, venture backed group of industry veterans that creates simple, focused software for the global drug trial industry. Its products offer drug trial sponsors and clinical research organizations the fastest, easiest possible way to start clinical studies on the web.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/21/2018 via BusinessWire

Anju Software, acquired Sylogent

synopsis: Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, has acquired Sylogent. Sylogent delivers cloud based state of the art software solutions and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market.
buyer parent: Providence Equity Partners Inc.
buyer: Anju Software
Anju Software is a life sciences enterprise software platform focused on delivering exceptional business application solutions. Anju was founded by professionals with deep software domain expertise and a track record of building software platforms through strategic acquisitions and organic growth. "
target: Sylogent
Sylogent delivers software and business services to the pharmaceutical industry focused specifically on the information required to bring a product to market. They ensure the timely completion of critical information, maximize compliance goals and reduce risk management liability.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/9/2017 via Company Press Release

PRA Health Sciences, acquired Parallel 6

synopsis: HCAP Partners, a California-based mezzanine debt and private equity firm, announced that it has exited its investment in Parallel 6, Inc. (“P6”), a mobile clinical (“mClinical”) SaaS platform designed to recruit, enroll, engage and manage patients in clinical trials. P6 was sold to PRA Health Sciences, Inc.
buyer parent: Kohlberg Kravis Roberts & Co.
buyer: PRA Health Sciences (PRAH:$1,698.48)
PRA Health Sciences, Inc. is one of the world’s leading global CROs by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. "
target parent: HCAP Partners
target: Parallel 6
Parallel 6’s technology digitally enrolls, engages and manages patients using mobile endpoints. Sponsors and clinical research organizations can connect directly with and manage patients anywhere in the world, seamlessly integrating into their daily lives.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/16/2016 via BNC Analysis

DrugDev, acquired SecureConsent

synopsis: DrugDev has acquired SecureConsent, a developer of mobile e-consent software. SecureConsent replaces the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
buyer: DrugDev
DrugDev streamlines engagement among sponsors, CROs and doctors to advance the common goal of doing more trials. Through the creation of global, standardized processes DrugDev is consistently and efficiently transforming the way drug developers identify, engage and pay investigators. "
target: SecureConsent
The software products developed by Secure Consent replace the paper methods that have historically been used to secure informed consent from patients participating in drug studies with an e-consent method that uses tablets and other mobile devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/19/2016 via PR Newswire

BioClinica, Inc., acquired Clinverse, Inc.

synopsis: Bioclinica, Inc., a specialty trials services and technology provider, announced it has acquired Clinverse, Inc. Clinverse automates and manages the entire financial lifecycle of global clinical trials for contract research organizations and pharmaceutical companies. Its suite of products pays clinical trial sites, vendors and their subjects.
buyer: BioClinica, Inc.
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized into three business segments to deliver focused service and multifaceted technologies. "
target: Clinverse, Inc.
Clinverse, Inc. architected the industry's first automated financial management technology solution for clinical trials. Their solution standardizes clinical trial financial management for millions of financial transactions across the globe, including clinical site payments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/17/2015 via PR Web

Aris Global LLC, acquired Medsight Solutions Inc.

synopsis: ArisGlobal®, a leading provider of Cloud solutions to life sciences companies, is pleased to announce that it has acquired Medsight Solutions, including the revolutionary integrated risk management solution, Medsight Sapphire (now known as ArisGlobal agBalance™).
buyer: Aris Global LLC
For more than 20 years, ArisGlobal has led in the development of innovative software solutions for pharmacovigilance & safety, regulatory affairs, clinical research and medical information. "
target: Medsight Solutions Inc.
Medsight Solutions Inc. is a life sciences solutions and professional services company with specialties in Clinical trial optimization, Benefit-risk assessment and Compliance monitoring.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2014 via PR Newswire

PAREXEL International Corporation, acquired ClinIntel Ltd.

synopsis: PAREXEL International Corporation, a global clinical research organization, announced that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom.
buyer: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. "
target: ClinIntel Ltd.
Headquartered in the United Kingdom, ClinIntel is a provider of clinical Randomization and Trial Supply Management (RTSM) services. The company was founded in 2009, and works with biopharmaceutical companies and contract research organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/24/2014 via PR Newswire

The WIRB-Copernicus Group, acquired ePharmaSolutions, Inc.

synopsis: WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced that ePharmaSolutions (ePS) has joined its group of companies. ePharmaSolutions is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's largest provider of regulatory and ethical solutions for clinical research, including Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) review. "
target: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of eClinical solutions and specialty clinical services that help improve the way trial sites are selected, trained, activated and managed to exceed enrollment goals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via PR Newswire

BioClinica, Inc., acquired Blueprint Clinical

synopsis: BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.
buyer parent: JLL Partners
buyer: BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization, electronic data capture, randomization, and clinical trial management. "
target: Blueprint Clinical
Blueprint Clinical, Inc. creates Software-as-a-Service tools that help improve monitoring of clinical trials. Their first product, Blueprint Clinical Compass™, ultimately allows risk based monitoring implementation thereby improving quality and efficiency of clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/29/2012 via Market Wire

Oracle Corporation, will acquire ClearTrial, LLC.

synopsis: Oracle announced that it has entered into an agreement to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations (CTO) applications that make the planning, sourcing, and tracking of clinical projects and financial performance faster and more accurate.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle Corporation is the world's largest enterprise software company. The company is a leading provider of systems software, including database management, application development, and application server software. "
target: ClearTrial, LLC.
ClearTrial, LLC provides software-as-a-service based Clinical Trial Operations software for planning, forecasting, and tracking clinical project and financial performance. The company serves biopharmaceutical companies, CROs, medical device companies, and small biotechs worldwide.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2011 via Company Press Release

Medidata Solutions Worldwide, acquired Clinical Force Inc.

synopsis: Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, has acquired Clinical Force, a pioneer in providing SaaS-based clinical trial management systems (CTMS), for undisclosed proceeds.
buyer: Medidata Solutions Worldwide (MDSO:$660.00)
Medidata Solutions is a leading global provider of SaaS clinical development solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced solutions lower the total cost of clinical development by optimizing clinical trials from concept to conclusion. "
target: Clinical Force Inc.
Clinical Force is a privately-held company with a strong life science pedigree and offices in the US and Europe. It delivers a fully functional Clinical Trials Management System (CTMS) deployed in four continents. Clinical Force has extensive experience in CROs and sponsors.
price ($mm)
$4.40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/16/2010 via Market Wire

Phase Forward will be merged with Oracle Corporation,

synopsis: Oracle announced that it has agreed to acquire Phase Forward, a leading provider of applications for life sciences companies and healthcare providers, through a cash merger for $17.00 per share, or approximately $685 million.
buyer: Oracle Corporation (ORCL:$39,766.00)
Oracle is the world's largest enterprise software company. The company is a leading provider of systems software, including database management, application development, and application server software. "
target: Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture, clinical data management and clinical data analysis and reporting automation and compliance.
price ($mm)[EV]
$699 [$569]
rev ($mm)
$222
EBITDA ($mm)
$30
EV / rev
2.7x
EV / EBITDA
19.5x

Like Patient Profiles, LLC


read more

Patient Profiles, LLC

PharmaCM

Comprehend Systems, Inc.

eClinical Insights, Inc.

Axxiem Web Solutions

eResearch Technology, Inc.

etrials, Inc.

Phoenix Data Systems Inc.

karmadata

Dataline Software

Medimix International

Relay Technology Management

Image Solutions, Inc.

Apyx, Inc.

BSI Business Systems Integration

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

read more

Patient Profiles, LLC

read more

Medidata

SHYFT Analytics

Mytrus, Inc.

CHITA

Intelemage

Patient Profiles, LLC

Clinical Force Inc.

Fast Track Systems, Inc.

read more

Patient Profiles, LLC

Viedoc

Clinical Trial Connect, LLC

THREAD Research

OmniComm Systems, Inc.

Medidata

Custodix N.V.

GoBalto

Sylogent

Parallel 6

SecureConsent

Clinverse, Inc.

Medsight Solutions Inc.

ClinIntel Ltd.

ePharmaSolutions, Inc.

Blueprint Clinical

DecisionView, Inc.

ClearTrial, LLC.

Clinical Force Inc.

Phase Forward

Geography
Matching Companies
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2019
rev ($mm)
$30.83
EBITDA ($mm)
$4.12
EBIT ($mm)
$3.15
Net Income ($mm)
$2.27
Employees
238
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: SLP
 
 
 
 
 
 
 
 
Simulations Plus, Inc.
Simulations Plus, Inc.
Simulations Plus, Inc. is a premier developer of groundbreaking drug discovery and development simulation and modeling software that is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.
year
2019
rev ($mm)
$35.84
EBITDA ($mm)
$12.38
EBIT ($mm)
$11.28
Net Income ($mm)
$9.11
Employees
109
  • drill down
  • watch
Ticker: POAI
 
 
 
 
 
 
 
 
Predictive Oncology Inc.
Predictive Oncology Inc.
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery. Predictive Oncology operates through five segments which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe.
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($13.26)
EBIT ($mm)
($13.71)
Net Income ($mm)
Employees
24
  • drill down
  • watch
Ticker: OMCL
 
 
 
 
 
 
 
 
Omnicell, Inc.
Omnicell, Inc.
Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
year
2020
rev ($mm)
$906.40
EBITDA ($mm)
$100.91
EBIT ($mm)
$61.95
Net Income ($mm)
$49.09
Employees
2780
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: MRCY
 
 
 
 
 
 
 
 
Mercury Computer Systems, Inc.
Mercury Computer Systems, Inc.
Mercury Computer Systems is the leading supplier of high-performance digital signal and image processing systems. These embedded computer systems transform streams of sensor data to visual information in real time for analysis and interpretation.
year
2011
rev ($mm)
$228.71
EBITDA ($mm)
$33.90
EBIT ($mm)
$25.55
Net Income ($mm)
$18.44
Employees
602
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: CNSX:PHGI
 
 
 
 
 
 
 
 
Premier Health Group Inc.
Premier Health is strategically poised to take advantage of business opportunities in the global health care industry. Their subsidiary, HealthVue, is focused on developing proprietary technology to deliver quality healthcare through the combination of telemedicine and artificial intelligence (AI).
year
2020
rev ($mm)
$7.80
EBITDA ($mm)
($4.43)
EBIT ($mm)
($4.59)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TRHC
 
 
 
 
 
 
 
 
Tabula Rasa Healthcare
Tabula Rasa Healthcare
Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: ZMD
 
 
 
 
 
 
 
 
ZoomMed Inc.
ZoomMed Inc.
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and various other stakeholders of the healthcare sector.
year
2014
rev ($mm)
$6.08
EBITDA ($mm)
$2.65
EBIT ($mm)
$2.78
Net Income ($mm)
Employees
40
  • drill down
  • watch
Ticker: ASX:MDR
 
 
 
 
 
 
 
 
MedAdvisor Limited
MedAdvisor Limited
MedAdvisor is a world class medication management platform focused on addressing the gap and burden of medication adherence. The highly automated Australian software system connects patients to their local pharmacy, providing them with real time access to their personal medication records.
year
2016
rev ($mm)
$1.05
EBITDA ($mm)
($2.13)
EBIT ($mm)
($2.15)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:INS
 
 
 
 
 
 
 
 
Instem
Instem
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide.
year
2019
rev ($mm)
$30.83
EBITDA ($mm)
$4.12
EBIT ($mm)
$3.15
Net Income ($mm)
$2.27
Employees
238
  • drill down
  • watch
Ticker: SYPT
 
 
 
 
 
 
 
 
Scrypt, Inc.
Scrypt, Inc.
Since 1998, Austin-based Scrypt, Inc. has been creating elegant document productivity tools for healthcare that eliminate manual processes and paper to save time and money. Scrypt has more than 30,000 customers across all 50 states.
year
2009
rev ($mm)
$0.27
EBITDA ($mm)
($0.85)
EBIT ($mm)
($0.91)
Net Income ($mm)
Employees
7
  • drill down
  • watch
Ticker: DATA
 
 
 
 
 
 
 
 
DATATRAK International, Inc.
DATATRAK International, Inc.
DATATRAK International, Inc. is a worldwide ASP for the EDC industry. The Company provides a suite of software products supporting the use of DATATRAK EDC(TM) and related services to the pharmaceutical, biotechnology, and medical device industries.
year
2012
rev ($mm)
$9.72
EBITDA ($mm)
($1.37)
EBIT ($mm)
($1.53)
Net Income ($mm)
Employees
  • drill down
  • watch